Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (18094)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 27, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World J Hepatol 2019; 11(1): 1-18 [PMID: 30705715 DOI: 10.4254/wjh.v11.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v11/i1/1.htm |
| Number | Citing Articles |
| 1 |
Hala S. El-Rebey, Asmaa G. Abdou, Mervat M. Sultan, Shymaa H. Ibrahim, Nanis S. Holah. The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: An Immunohistochemical Study. Applied Immunohistochemistry & Molecular Morphology 2021; 29(3): 188 doi: 10.1097/PAI.0000000000000865
|
| 2 |
L.E. Cisneros-Garza, M.S. González-Huezo, C. Moctezuma-Velázquez, L. Ladrón de Guevara-Cetina, M. Vilatobá, I. García-Juárez, R. Alvarado-Reyes, G.A. Álvarez-Treviño, S. Allende-Pérez, L. Bornstein-Quevedo, G. Calderillo-Ruiz, M.A. Carrillo-Martínez, M. Castillo-Barradas, E. Cerda-Reyes, J.A. Félix-Leyva, J.A. Gabutti-Thomas, J. Guerrero-Ixtlahuac, F. Higuera-de-la-Tijera, D. Huitzil-Meléndez, E. Kimura-Hayama, P.A. López-Hernández, R. Malé-Velázquez, N. Méndez-Sánchez, M.A. Morales-Ruiz, E. Ruíz-García, J.F. Sánchez-Ávila, L. Torrecillas-Torres. The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosis. Revista de Gastroenterología de México (English Edition) 2022; 87(2): 216 doi: 10.1016/j.rgmxen.2021.10.009
|
| 3 |
Mikael Sawatzki, Daniela B. Husarik, David Semela. Assessment of focal liver lesions in non-cirrhotic liver – expert opinion statement by the Swiss Association for the Study of the Liver and the Swiss Society of Gastroenterology. Swiss Medical Weekly 2023; 153(9): 40099 doi: 10.57187/smw.2023.40099
|
| 4 |
Joanne McDonagh, Sara Bardell, Neil Rajoriya, Isobel Hayes, Tahir Shah. Managing ascites in patients with hepatocellular carcinoma: experiences from a quaternary liver centre. Gastrointestinal Nursing 2024; 22(Sup1): S17 doi: 10.12968/gasn.2024.22.Sup1.S17
|
| 5 |
Misako Nagasaka, Bayan Al-Share, Yusra F. Shao, Rachel Sexton, Mohammed Najeeb Al Hallak, Asfar S. Azmi, Ammar Sukari. Comprehensive Gut Microbiota. 2022; : 339 doi: 10.1016/B978-0-12-819265-8.00047-4
|
| 6 |
Omayma A.R. AboZaid, Mostafa A. Abdel-Maksoud, Ibrahim A. Saleh, Mohamed A. El-Tayeb, Sawsan M. EL-sonbaty, Faten E. Shoker, Maha A. Salem, Ayat M. Emad, Samson Mani, Arunagiri Kuha Deva Magendhra Rao, Mohamed A. Mamdouh, Mohamed H. Kotob, Mohammed Aufy, Ahmad S. Kodous. Targeting the NF-κB p65/Bcl-2 signaling pathway in hepatic cellular carcinoma using radiation assisted synthesis of zinc nanoparticles coated with naturally isolated gallic acid. Biomedicine & Pharmacotherapy 2024; 172: 116274 doi: 10.1016/j.biopha.2024.116274
|
| 7 |
Siyu Fu, José D. Debes, André Boonstra. DNA methylation markers in the detection of hepatocellular carcinoma. European Journal of Cancer 2023; 191: 112960 doi: 10.1016/j.ejca.2023.112960
|
| 8 |
Daniel Jesper, Daniel Klett, Barbara Schellhaas, Lukas Pfeifer, Moritz Leppkes, Maximilian Waldner, Markus F. Neurath, Deike Strobel. Ultrasound-Based Attenuation Imaging for the Non-Invasive Quantification of Liver Fat - A Pilot Study on Feasibility and Inter-Observer Variability. IEEE Journal of Translational Engineering in Health and Medicine 2020; 8: 1 doi: 10.1109/JTEHM.2020.3001488
|
| 9 |
Stefania Brozzetti, Marsia Tancredi, Simone Bini, Chiara De Lucia, Jessica Antimi, Chiara D’Alterio, Giuseppe Maria De Sanctis, Caterina Furlan, Vittoria Carolina Malpassuti, Pierleone Lucatelli, Michele Di Martino, Mario Bezzi, Antonio Ciardi, Rosa Maria Pascale. HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the Elderly. Cancers 2021; 13(12): 3025 doi: 10.3390/cancers13123025
|
| 10 |
Suzan Abdu, Nouf Juaid, Amr Amin, Mohamed Moulay, Nabil Miled. Therapeutic Effects of Crocin Alone or in Combination with Sorafenib against Hepatocellular Carcinoma: In Vivo & In Vitro Insights. Antioxidants 2022; 11(9): 1645 doi: 10.3390/antiox11091645
|
| 11 |
Clara T. Nicolas, Caitlin J. VanLith, Raymond D. Hickey, Zeji Du, Lori G. Hillin, Rebekah M. Guthman, William J. Cao, Benjamin Haugo, Annika Lillegard, Diya Roy, Aditya Bhagwate, Daniel O’Brien, Jean-Pierre Kocher, Robert A. Kaiser, Stephen J. Russell, Joseph B. Lillegard. In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions. Nature Communications 2022; 13(1) doi: 10.1038/s41467-022-32576-7
|
| 12 |
Fabio Sandomenico, Valerio Arpaia, Ferdinando De Rosa, Orlando Catalano, Roberto Antonino Buonaiuto, Marianna Notarangelo, Maria Iovino, Sabrina Giovine, Arturo Brunetti, Mariano Scaglione. Spontaneously Ruptured Hepatocellular Carcinoma: Computed Tomography-Based Assessment. Diagnostics 2023; 13(6): 1021 doi: 10.3390/diagnostics13061021
|
| 13 |
Mario Capasso, Valentina Cossiga, Maria Guarino, Luisa Ranieri, Filomena Morisco. The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis. Cancers 2024; 16(8): 1505 doi: 10.3390/cancers16081505
|
| 14 |
Yi Dong, Wen-Ping Wang, Won Jae Lee, Maria Franca Meloni, Dirk-Andre Clevert, Maria Cristina Chammas, Andrea Tannapfel, Antonella Forgione, Fabio Piscaglia, Christoph Frank Dietrich. Hepatocellular carcinoma in the non-cirrhotic liver. Clinical Hemorheology and Microcirculation 2022; 80(4): 423 doi: 10.3233/CH-211309
|
| 15 |
Yilin Pang, Yuanshan Lin, Xueqing Wang, Jing Wang, Qian Liu, Nan Ding, Lin Huang, Qiyu Xiang, Jun Fang, Guoqiang Tan, Jianxin Lyu, Zheng Wang. Inhibition of abnormally activated HIF-1α-GLUT1/3-glycolysis pathway enhances the sensitivity of hepatocellular carcinoma to 5-caffeoylquinic acid and its derivatives. European Journal of Pharmacology 2022; 920: 174844 doi: 10.1016/j.ejphar.2022.174844
|
| 16 |
K. P. Divya, Parneet Hari, Navjot Kanwar, Navita Aggarwal, Preeti Singh Dhoat, Lu Liu, Abhinav Kanwal, Shailendra Pratap Singh, Jiong Yu. The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics. Advanced Gut & Microbiome Research 2023; 2023: 1 doi: 10.1155/2023/5431615
|
| 17 |
Yakup Ülger, Anıl Delik. AN UNUSUAL CASE OF RECURRENT GASTROINTESTINAL BLEEDING AND ACUTE RENAL FAILURE-RELATED HEPATOCELLULAR CARCINOMA WITH GASTRIC OUTLET OBSTRUCTION. Gastroenterology Nursing 2022; 45(5): 370 doi: 10.1097/SGA.0000000000000694
|
| 18 |
Ahdab S Bawashkhah, Ghufran A Sindi, Shahad B Almatrafi, Elaf F Obaid, Reda I Bakhsh. Fibrolamellar Hepatocellular Carcinoma in the Absence of Risk Factors: A Case Report. Cureus 2022; doi: 10.7759/cureus.32483
|
| 19 |
Gitanjali Bajaj, Karthik Sundaram, Kedar Jambhekar, Roopa Ram. Imaging After Locoregional Therapy for Hepatocellular Carcinoma With Emphasis on LIRADS Treatment Response Assessment Criteria. Seminars in Ultrasound, CT and MRI 2021; 42(4): 390 doi: 10.1053/j.sult.2021.03.002
|
| 20 |
Ellery Altshuler, Raymond Richhart, Mahmoud Aryan, William King, Kelsey Pan, Akash Mathavan, Akshay Mathavan, Diana Rodriguez, Bishal Paudel, Nathan Northern, Brian Ramnaraign, Ilyas Sahin, Jesus C Fabregas. Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review. Journal of Hepatocellular Carcinoma 2022; : 1299 doi: 10.2147/JHC.S384438
|
| 21 |
Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development. Journal of Clinical Medicine 2021; 10(5): 977 doi: 10.3390/jcm10050977
|
| 22 |
Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A-miR-122 Feedback Loop in Liver Fibrosis and Cancer Progression. Cancers 2019; 11(10): 1407 doi: 10.3390/cancers11101407
|
| 23 |
Sayed Metwaly, Alicja Psica, Opeyemi Sogaolu, Irfan Ahmed, Ashis Mukhopadhya, Mirela Delibegović, Mohamed Bekheit. Volatile organic compounds for the detection of hepatocellular carcinoma—A scoping review. iLIVER 2024; 3(1): 100070 doi: 10.1016/j.iliver.2023.09.001
|
| 24 |
Bisha Ding, Weiyang Lou, Jingxing Liu, Ruohan Li, Jing Chen, Weimin Fan. In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0901-3
|
| 25 |
Jack Leslie, Daniel Geh, Ahmed M. Elsharkawy, Derek A. Mann, Michele Vacca. Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions. Journal of Hepatology 2022; 77(1): 219 doi: 10.1016/j.jhep.2022.01.029
|
| 26 |
Monica Pibiri, Gabriella Simbula. Role of the Hippo pathway in liver regeneration and repair: recent advances. Inflammation and Regeneration 2022; 42(1) doi: 10.1186/s41232-022-00235-5
|
| 27 |
Yi-Te Lee, Benjamin V. Tran, Jasmine J. Wang, Icy Y. Liang, Sungyong You, Yazhen Zhu, Vatche G. Agopian, Hsian-Rong Tseng, Ju Dong Yang. The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma. Cancers 2021; 13(12): 3076 doi: 10.3390/cancers13123076
|
| 28 |
Coskun Ozer Demirtas, Maurizia Rossana Brunetto. Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?. World Journal of Gastroenterology 2021; 27(33): 5536-5554 doi: 10.3748/wjg.v27.i33.5536
|
| 29 |
Markus Casper, Maximilian Linxweiler, Johannes Linxweiler, Richard Zimmermann, Matthias Glanemann, Frank Lammert, Susanne N. Weber. <b><i>SEC62</i></b> and <b><i>SEC63</i></b> Expression in Hepatocellular Carcinoma and Tumor-Surrounding Liver Tissue. Visceral Medicine 2021; 37(2): 110 doi: 10.1159/000513293
|
| 30 |
Elizabeth SL Low, Ross Apostolov, Darren Wong, Sandra Lin, Numan Kutaiba, Josephine A Grace, Marie Sinclair. Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients. World Journal of Gastrointestinal Oncology 2021; 13(12): 2149-2160 doi: 10.4251/wjgo.v13.i12.2149
|
| 31 |
Khaled Mahmoud, Shady Swidan, Mohamed El-Nabarawi, Mahmoud Teaima. Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01309-9
|
| 32 |
Hongxin Cai, Xiaoyue Du, Yufeng Deng, Dejian Cao, Lele Wang, Zhiguo Wu, Xianchao Zhang, Jinbiao Xu, Baogang Xie. Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats. Bioanalysis 2024; doi: 10.4155/bio-2023-0215
|
| 33 |
Gianvito Candita, Sara Rossi, Karolina Cwiklinska, Salvatore Claudio Fanni, Dania Cioni, Riccardo Lencioni, Emanuele Neri. Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review. Diagnostics 2023; 13(4): 625 doi: 10.3390/diagnostics13040625
|
| 34 |
Juey-Ming Shih. Tumor Lysis Syndrome Following Thoracotomy Under Cardiopulmonary Bypass in a Case of Hepatocellular Carcinoma With Right Atrial and Inferior Vena Cava Tumor Thrombus. Cureus 2021; doi: 10.7759/cureus.20311
|
| 35 |
Dafeng Xu, Yu Wang, Jincai Wu, Yuliang Zhang, Zhehao Liu, Yonghai Chen, Jinfang Zheng. Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.686664
|
| 36 |
Mahnaz Mohammadi, Adeleh Attar, Maryam Mohammadbeigi, Amir Peymani, Shahin Bolori, Fatemeh Fardsanei. The possible role of Helicobacter pylori in liver diseases. Archives of Microbiology 2023; 205(8) doi: 10.1007/s00203-023-03602-z
|
| 37 |
Mauro Cataldi, Federica Manco, Giovanni Tarantino. Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story. International Journal of Molecular Sciences 2021; 22(23): 12947 doi: 10.3390/ijms222312947
|
| 38 |
Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho. Interventional Management of Portal Hypertension in Cancer Patients. Current Oncology Reports 2022; 24(11): 1461 doi: 10.1007/s11912-022-01319-8
|
| 39 |
Mélanie Simoes Eugénio, Muhammad Farooq, Sarah Dion, Christelle Devisme, Céline Raguenes-Nicol, Claire Piquet-Pellorce, Michel Samson, Marie-Thérèse Dimanche-Boitrel, Jacques Le Seyec. Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response. Cancers 2020; 12(6): 1491 doi: 10.3390/cancers12061491
|
| 40 |
Yi Dong, Sheng Chen, Kathleen Möller, Yi-Jie Qiu, Xiu-Yun Lu, Qi Zhang, Christoph F. Dietrich, Wen-Ping Wang. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver. Ultrasound in Medicine & Biology 2023; 49(8): 1780 doi: 10.1016/j.ultrasmedbio.2023.03.026
|
| 41 |
Dobrochna Dolicka, Cyril Sobolewski, Marta Correia de Sousa, Monika Gjorgjieva, Michelangelo Foti. mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and Cancer. International Journal of Molecular Sciences 2020; 21(18): 6648 doi: 10.3390/ijms21186648
|
| 42 |
Georgi Atanasov, Karoline Dino, Katrin Schierle, Corinna Dietel, Gabriela Aust, Johann Pratschke, Daniel Seehofer, Moritz Schmelzle, Hans-Michael Hau. Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1756-8
|
| 43 |
Valentina Liakina, Sandra Strainiene, Ieva Stundiene, Vaidota Maksimaityte, Edita Kazenaite. Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis. World Journal of Hepatology 2022; 14(7): 1277-1290 doi: 10.4254/wjh.v14.i7.1277
|
| 44 |
McKenzie J. White, Eric H. Jensen, David G. Brauer. A Review of Resection and Surgical Ablation for Primary and Secondary Liver Cancers. Seminars in Interventional Radiology 2023; 40(06): 536 doi: 10.1055/s-0043-1777747
|
| 45 |
Amreen Dinani, Norman Sussman, Mazen Noureddin, Michael Fuchs, George Therapondos, Nigel Girgrah, Viviana Figueroa Diaz, Parvez Mantry, Mary Rinella, Amon Asgharpour, Douglas Dieterich. An algorithm for the management of non-alcoholic fatty liver disease in primary care. Gastroenterology & Hepatology: Open Access 2021; 12(4): 114 doi: 10.15406/ghoa.2021.12.00469
|
| 46 |
A. Riojas-Garza, M. González-Urquijo, C.E. Escareño-Pérez, I. Vázquez-Ávila, F.J. Bosques-Padilla. Carcinoma hepatocelular de lóbulo caudado en un paciente no cirrótico con historia de administración de fenitoína crónica y enfermedad celíaca tratada con resección aislada de lóbulo caudado. Un reporte de caso. Revista de Gastroenterología de México 2022; 87(2): 256 doi: 10.1016/j.rgmx.2022.03.001
|
| 47 |
Maryam Bilal Haider, Ali Al Sbihi, Ahmed Jamal Chaudhary, Syed M Haider, Ahmed Iqbal Edhi. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study. World Journal of Hepatology 2022; 14(9): 1804-1816 doi: 10.4254/wjh.v14.i9.1804
|
| 48 |
Qiaoling Wang, Binxia Chang, Xiaoyan Li, Zhengsheng Zou. Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis. Journal of Clinical and Translational Hepatology 2021; 0(000): 1 doi: 10.14218/JCTH.2020.00104
|
| 49 |
Hiroko Naganuma, Hideaki Ishida. Hepatocellular Carcinoma in Non-Fibrotic Liver: A Narrative Review. Diagnostics 2023; 13(22): 3426 doi: 10.3390/diagnostics13223426
|
| 50 |
Monika Péčová, Jakub Benko, Martin Jozef Péč, Jakub Jurica, Simona Horná, Tomáš Bolek, Tatiana Hurtová, Ján Sýkora, Kamil Zeleňák, Matej Samoš, Juraj Sokol. A Rare Early-Onset Fatal Complication after Transarterial Chemoembolization: A Case Report and Review of the Literature. Current Oncology 2024; 31(4): 1961 doi: 10.3390/curroncol31040147
|
| 51 |
Raja Chhabra, Aditya Vidushi, Sajjan Rajpurohit, Jasbir Singh, Md Ali Osama. Spontaneous Tumor Lysis Syndrome in a Case of Hepatocellular Carcinoma with Sarcomatoid Differentiation. Indian Journal of Surgical Oncology 2024; doi: 10.1007/s13193-024-01895-0
|
| 52 |
Mattias Lissing, Bruce Wang, Staffan Wahlin. Liver transplantation and primary liver cancer in porphyria. Liver International 2024; doi: 10.1111/liv.15894
|
| 53 |
Moris Sangineto, Rosanna Villani, Francesco Cavallone, Antonino Romano, Domenico Loizzi, Gaetano Serviddio. Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma. Cancers 2020; 12(6): 1419 doi: 10.3390/cancers12061419
|
| 54 |
Nur Fatin Najihah Marzuki, Yusmazura Zakaria. Medicinal Plants in the Regulation of PD-L1/PD-1 Immune Checkpoint of
Various Human Cancer Cells: A Narrative Review. Current Cancer Therapy Reviews 2023; 19(2): 117 doi: 10.2174/1573394718666220829125338
|
| 55 |
Paolo Gallo, Marianna Silletta, Federica Lo Prinzi, Tommaso Farolfi, Alessandro Coppola. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease. Journal of Clinical Medicine 2023; 12(14): 4605 doi: 10.3390/jcm12144605
|
| 56 |
Hiroki Bessho, Satoshi Tanaka, Akio Ishihara, Shinya Kato, Reishi Toshiyama, Naoki Hama, Kiyoshi Mori, Masayuki Mano, Atsushi Miyamoto, Hisashi Ishida, Motohiro Hirao, Eiji Mita. Hepatocellular carcinoma in an adult patient with congenital absence of the portal vein type II: A case report. JGH Open 2020; 4(4): 766 doi: 10.1002/jgh3.12312
|
| 57 |
Rong Liu, Ming-Ping Qian, Ying-Yu Cui. Protein kinases: The key contributors in pathogenesis and treatment of nonalcoholic fatty liver disease-derived hepatocellular carcinoma. Metabolism 2023; 147: 155665 doi: 10.1016/j.metabol.2023.155665
|
| 58 |
Edgar Xchel Franco-Juárez, Vianey González-Villasana, María Elena Camacho-Moll, Luisa Rendón-Garlant, Patricia Nefertari Ramírez-Flores, Beatriz Silva-Ramírez, Katia Peñuelas-Urquides, Ethel Daniela Cabello-Ruiz, Fabiola Castorena-Torres, Mario Bermúdez de León. Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(3): 1760 doi: 10.3390/ijms25031760
|
| 59 |
Benedetta Maria Motta, Mario Masarone, Pietro Torre, Marcello Persico. From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention. Cancers 2023; 15(22): 5458 doi: 10.3390/cancers15225458
|
| 60 |
Maria Cristina Cuartas-Mesa, Maria E Romero Noboa, Yasmine Choroomi, Badri Aryal, Akash Venkataramanan, Rafaella Ferreira de Araujo Litvin. A Chronic Cough and Something More: An Unusual Presentation of Hepatocellular Carcinoma. Cureus 2023; doi: 10.7759/cureus.37300
|
| 61 |
Song-Chen Dong, Dou-Sheng Bai, Fu-An Wang, Sheng-Jie Jin, Chi Zhang, Bao-Huan Zhou, Guo-Qing Jiang. Radiofrequency ablation is an inferior option to liver resection for solitary hepatocellular carcinoma ≤ 5 cm without cirrhosis: A population-based study with stratification by tumor size. Hepatobiliary & Pancreatic Diseases International 2023; 22(6): 605 doi: 10.1016/j.hbpd.2022.08.001
|
| 62 |
Anna Michelotti, Marco de Scordilli, Lorenza Palmero, Michela Guardascione, Mario Masala, Rossana Roncato, Luisa Foltran, Elena Ongaro, Fabio Puglisi. NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome. Cells 2021; 10(8): 2034 doi: 10.3390/cells10082034
|
| 63 |
Aditya Kale. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.99839
|
| 64 |
|
| 65 |
Shohei Kurokawa, Toshiyuki Tanaka, Hiroki Yamazaki, Shunsuke Noguchi, Yusuke Wada, Hidetaka Nishida, Hideo Akiyoshi. Comparing the CT and MRI findings for canine primary hepatocellular lesions. Veterinary Record 2022; 190(11) doi: 10.1002/vetr.1083
|
| 66 |
Runmin Cao, Honghe Jiang, Guangpeng Liang, Weibin Zhang. SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(13): 12033 doi: 10.1007/s00432-023-05057-7
|
| 67 |
Sehwa Kim, Yoonseok Lee, Soo Min Bang, Haein Bak, Sun Young Yim, Young Sun Lee, Yang Jae Yoo, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Soon Ho Um, Kwan Soo Byun, Jong Eun Yeon. Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients. Journal of Clinical Medicine 2021; 10(9): 1840 doi: 10.3390/jcm10091840
|
| 68 |
Kanokwan Pinyopornpanish, Wael Al-Yaman, Srinivasan Dasarathy, Carlos Romero-Marrero, Arthur McCullough. Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival. Digestive Diseases and Sciences 2022; 67(6): 2677 doi: 10.1007/s10620-021-07048-5
|
| 69 |
Bjarki Sigurdsson, Ragna Sigurdardottir, Margret B. Arnardottir, Sigrun H. Lund, Jon G. Jonasson, Einar S. Björnsson. A nationwide study on hepatocellular carcinoma. Cancer Epidemiology 2020; 69: 101835 doi: 10.1016/j.canep.2020.101835
|
| 70 |
Poonamjeet Loyal, Samuel Gitau, Soraiya Manji, Sitna Mwanzi, John Weru. Unusual presentation of hepatocellular carcinoma: Case report and review of literature. BJR|case reports 2021; 7(4): 20210033 doi: 10.1259/bjrcr.20210033
|
| 71 |
Juan Pang, Ke Chen, Shen Chen, Xu Chen. Global burden of nonalcoholic steatohepatitis-related liver cancer, 1990–2019: a systematic analysis for the GBD 2019. Diabetology & Metabolic Syndrome 2022; 14(1) doi: 10.1186/s13098-022-00885-y
|
| 72 |
Amira M. Elmoslemany, Mohamed Elzallat, Mai Hussein Abd-Elfatah, Dina Mostafa Mohammed, Eman E.Abd Elhady. Possible therapeutic effect of frankincense (Gum olibanum) and myrrh (Commiphora myrrha) resins extracts on DEN/CCL4 induced hepatocellular carcinoma in rats. Phytomedicine Plus 2024; 4(1): 100517 doi: 10.1016/j.phyplu.2023.100517
|
| 73 |
Emma A. Schindler, Melissa A. Gilbert, David A. Piccoli, Nancy B. Spinner, Ian D. Krantz, Kathleen M. Loomes. Alagille syndrome and risk for hepatocellular carcinoma: Need for increased surveillance in adults with mild liver phenotypes. American Journal of Medical Genetics Part A 2021; 185(3): 719 doi: 10.1002/ajmg.a.62028
|
| 74 |
Dandan Huang, Dafen Xu, Wenxin Chen, Ruimei Wu, Yujuan Wen, Ailin Liu, Liqing Lin, Xinhua Lin, Xuewen Wang. Fe-MnO2 nanosheets loading dihydroartemisinin for ferroptosis and immunotherapy. Biomedicine & Pharmacotherapy 2023; 161: 114431 doi: 10.1016/j.biopha.2023.114431
|
| 75 |
Matthew Thomas, Manjiri Dighe, Orpheus Kolokythas, Mladen Zecevic, Ann Wilson, Todd Erpelding, Theodore J. Dubinsky. Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and Liver Function for Assessing Degree of Steatosis in NAFLD and Non-NAFLD Patients. Ultrasound Quarterly 2023; 39(4): 188 doi: 10.1097/RUQ.0000000000000648
|
| 76 |
Hafiza Arooba Riaz, Dur E. Nishwa, Ameer Fatima, Braira Wahid, Akhtar Ali, Babita Kumari, Muhammad Idrees. Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis. Heliyon 2023; 9(5): e16169 doi: 10.1016/j.heliyon.2023.e16169
|
| 77 |
Diwakar Suresh, Akshatha N. Srinivas, Divya P. Kumar. Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.601710
|
| 78 |
Nicola Pugliese, Ludovico Alfarone, Ivan Arcari, Silvia Giugliano, Tommaso Lorenzo Parigi, Maria Rescigno, Ana Lleo, Alessio Aghemo. Clinical features and management issues of NAFLD-related HCC: what we know so far. Expert Review of Gastroenterology & Hepatology 2023; 17(1): 31 doi: 10.1080/17474124.2023.2162503
|
| 79 |
Nikita Sehgal, Ruchi Jakhmola Mani, Nitu Dogra, Deepshikha Pande Katare. Biosensor Based Advanced Cancer Diagnostics. 2022; : 97 doi: 10.1016/B978-0-12-823424-2.00009-0
|
| 80 |
Reshmi Mathew, Gregory Churchill, Bakht Cheema, Ketav Desai, Ahmad Alkhasawneh, Shiguang Liu, Anwer Siddiqi. Concomitant Gastric Malignancy and Hepatocellular Carcinoma. Cureus 2022; doi: 10.7759/cureus.25607
|
| 81 |
Robert Mahn, Farsaneh Sadeghlar, Alexandra Bartels, Taotao Zhou, Tobias Weismüller, Patrick Kupczyk, Carsten Meyer, Florian C. Gaertner, Marieta Toma, Tim Vilz, Petra Knipper, Tim Glowka, Steffen Manekeller, Jörg Kalff, Christian P. Strassburg, Maria A. Gonzalez-Carmona. Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation. Medicine 2021; 100(38): e27082 doi: 10.1097/MD.0000000000027082
|
| 82 |
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo. Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Cancers 2023; 15(7): 1925 doi: 10.3390/cancers15071925
|
| 83 |
Eloy Ruiz, Pascal Pineau, Claudio Flores, Ramiro Fernández, Luis Cano, Juan Pablo Cerapio, Sandro Casavilca-Zambrano, Francisco Berrospi, Ivan Chávez, Benjamin Roche, Stéphane Bertani. A preoperative nomogram for predicting long-term survival after resection of large hepatocellular carcinoma (>10 cm). HPB 2022; 24(2): 192 doi: 10.1016/j.hpb.2021.06.006
|
| 84 |
Ben L. Da, Aiwu Ruth He, Kirti Shetty, Kelly I. Suchman, Herbert Yu, Lawrence Lau, Linda L. Wong, Atoosa Rabiee, Richard L. Amdur, James M. Crawford, Sharon S. Fox, Gregory M. Grimaldi, Priya K. Shah, Jonathan Weinstein, David Bernstein, Sanjaya K. Satapathy, Nyasha Chambwe, Xiyan Xiang, Lopa Mishra. Pathogenesis to management of hepatocellular carcinoma. Genes & Cancer 2022; 13: 72 doi: 10.18632/genesandcancer.226
|
| 85 |
Cedric Brackenier, Lisa Kinget, Sarah Cappuyns, Chris Verslype, Benoit Beuselinck, Jeroen Dekervel. Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma. Cancers 2023; 15(2): 348 doi: 10.3390/cancers15020348
|
| 86 |
Jonathan H. Joachim, Kosha J. Mehta. Hepcidin in hepatocellular carcinoma. British Journal of Cancer 2022; 127(2): 185 doi: 10.1038/s41416-022-01753-2
|
| 87 |
Vassilis G. Giannakoulis, Peter Dubovan, Eleni Papoutsi, Agapi Kataki, John Koskinas. Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective. Cancers 2021; 13(18): 4732 doi: 10.3390/cancers13184732
|
| 88 |
Yakup Ülger, Anil Delik. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients. European Journal of Gastroenterology & Hepatology 2022; 34(7): 769 doi: 10.1097/MEG.0000000000002341
|
| 89 |
Yucel Aydin, Ali R. Koksal, Paul Thevenot, Kelley Nunez, Mohamed Elgamal, Ulkuhan I. Koksal, Tyler Sandow, Martin Moehlen, Frederic Regenstein, Veysel Tahan, Ari Cohen. The number of hepatocellular carcinoma foci as predictor of poor response to tumor-directed therapies in patients awaiting liver transplantation: a prospective cohort study. European Journal of Gastroenterology & Hepatology 2023; 35(10): 1224 doi: 10.1097/MEG.0000000000002631
|
| 90 |
Qian Huang, Xin Xin, QinMei Sun, Ziming An, Xiaojun Gou, Qin Feng. Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.896899
|
| 91 |
Pranathi Pappu, Urvashi Vijay, Dhatri Madduru, Ngalah Bidii Stephen, Prashanth Suravajhala, Obul Reddy Bandapalli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 281 doi: 10.1016/B978-0-323-98807-0.00005-3
|
| 92 |
Nazeer Ahmad Khan, Faisal Rashid, Muhammad Siraj Khan Jadoon, Saquib Jalil, Zulfiqar Ali Khan, Raha Orfali, Shagufta Perveen, Areej Al-Taweel, Jamshed Iqbal, Sohail Anjum Shahzad. Design, Synthesis, and Biological Evaluation of Novel Dihydropyridine and Pyridine Analogs as Potent Human Tissue Nonspecific Alkaline Phosphatase Inhibitors with Anticancer Activity: ROS and DNA Damage-Induced Apoptosis. Molecules 2022; 27(19): 6235 doi: 10.3390/molecules27196235
|
| 93 |
Matthew August Odenwald, Sonali Paul. Viral hepatitis: Past, present, and future. World Journal of Gastroenterology 2022; 28(14): 1405-1429 doi: 10.3748/wjg.v28.i14.1405
|
| 94 |
Ifrah Fatima, Neehar D. Parikh, Alisa Likhitsup. Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2024; 33(1): 43 doi: 10.1016/j.soc.2023.06.007
|
| 95 |
Liuliu Cheng, Shichuan Hu, Jinhu Ma, Yongheng Shu, Yanwei Chen, Bin Zhang, Zhongbing Qi, Yunmeng Wang, Yan Zhang, Yuwei Zhang, Ping Cheng. Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system. Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-021-00065-w
|
| 96 |
Antonia Reyes, Gerardo Ortiz, Luisa F. Duarte, Christian Fernández, Rosario Hernández-Armengol, Pablo A. Palacios, Yolanda Prado, Catalina A. Andrade, Linmar Rodriguez-Guilarte, Alexis M. Kalergis, Felipe Simon, Leandro J. Carreño, Claudia A. Riedel, Mónica Cáceres, Pablo A. González. Contribution of viral and bacterial infections to senescence and immunosenescence. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1229098
|
| 97 |
Chutian Wu, Yun Zhou, Min Wang, Guolin Dai, Xiongxiu Liu, Leizhen Lai, Shaohui Tang. Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.772487
|
| 98 |
Benoit Schmauch, Sarah S. Elsoukkary, Amika Moro, Roma Raj, Chase J. Wehrle, Kazunari Sasaki, Julien Calderaro, Patrick Sin-Chan, Federico Aucejo, Daniel E. Roberts. Combining a deep learning model with clinical data better predicts hepatocellular carcinoma behavior following surgery. Journal of Pathology Informatics 2023; : 100360 doi: 10.1016/j.jpi.2023.100360
|
| 99 |
Zurabi Lominadze, Mohammed Rifat Shaik, Dabin Choi, Duha Zaffar, Lopa Mishra, Kirti Shetty. Hepatocellular Carcinoma Genetic Classification. The Cancer Journal 2023; 29(5): 249 doi: 10.1097/PPO.0000000000000682
|
| 100 |
Sanaz Pashapour, Masoumeh Heshmati, Zahra Mousavi, Somayeh Esmaeili. The Cytotoxicity of the Chloroform and Petroleum Ether Fractional Extracts of Galium verum L. in HepG2 and HT29 Cell Lines. Journal of Kermanshah University of Medical Sciences 2020; 24(2) doi: 10.5812/jkums.101079
|
| 101 |
Chao Ma, Longkun Fan, Jingxian Wang, Lixia Hao, Jinqiu He. Hippo/Mst1 overexpression induces mitochondrial death in head and neck squamous cell carcinoma via activating β-catenin/Drp1 pathway. Cell Stress and Chaperones 2019; 24(4): 807 doi: 10.1007/s12192-019-01008-9
|
| 102 |
Neha Merchant, Sujatha Peela, Afroz Alam, Ganji Purnachandra Nagaraju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 161 doi: 10.1016/B978-0-323-99283-1.00025-2
|
| 103 |
Sachin Sharma, Shaikh Maryam Ghufran, Basundhara Das, Bornika Roy, Sampa Ghose, Subhrajit Biswas. Survivin expression is essential for early activation of hepatic stellate cells and fibrosis progression in chronic liver injury. Life Sciences 2021; 287: 120119 doi: 10.1016/j.lfs.2021.120119
|
| 104 |
Matthias Van Haele, Janne Snoeck, Tania Roskams. Human Liver Regeneration: An Etiology Dependent Process. International Journal of Molecular Sciences 2019; 20(9): 2332 doi: 10.3390/ijms20092332
|
| 105 |
Pablo Lozano Lominchar, Maitane Igone Orue-Echebarria, Lorena Martín, Cristina Julia Lisbona, María Magdalena Salcedo, Luis Olmedilla, Hemant Sharma, Jose Manuel Asencio, José Ángel López-Baena. Hepatic flow is an intraoperative predictor of early allograft dysfunction in whole-graft deceased donor liver transplantation: An observational cohort study. World Journal of Hepatology 2019; 11(9): 689-700 doi: 10.4254/wjh.v11.i9.689
|
| 106 |
C. Nelson Hayes, Peiyi Zhang, Kazuaki Chayama. Hepatocellular Carcinoma. 2019; : 95 doi: 10.15586/hepatocellularcarcinoma.2019.ch5
|
| 107 |
Puru Rattan, Carlos D. Minacapelli, Vinod Rustgi. The Microbiome and Hepatocellular Carcinoma. Liver Transplantation 2020; 26(10): 1316 doi: 10.1002/lt.25828
|
| 108 |
Nan Zhang, Hui Xu, A‐Hong Ren, Qian Zhang, Da‐Wei Yang, Te Ba, Zhen‐Chang Wang, Zheng‐Han Yang. Does Training in LI‐RADS Version 2018 Improve Readers' Agreement with the Expert Consensus and Inter‐reader Agreement in MRI Interpretation?. Journal of Magnetic Resonance Imaging 2021; 54(6): 1922 doi: 10.1002/jmri.27688
|
| 109 |
Shih-Wei Yang, Wei-Liang Chen, Wei-Te Wu, Chung-Ching Wang. Investigation on returning to work in liver cancer survivors in Taiwan: a 5-year follow-up study. BMC Public Health 2021; 21(1) doi: 10.1186/s12889-021-11872-9
|
| 110 |
Cemil Colak, Zeynep Kucukakcali, Sami Akbulut. Artificial intelligence-based prediction of molecular and genetic markers for hepatitis C–related hepatocellular carcinoma. Annals of Medicine & Surgery 2023; 85(10): 4674 doi: 10.1097/MS9.0000000000001210
|
| 111 |
Sonia Pascual, Cayetano Miralles, Juan M Bernabé, Javier Irurzun, Mariana Planells. Surveillance and diagnosis of hepatocellular carcinoma: A systematic review. World Journal of Clinical Cases 2019; 7(16): 2269-2286 doi: 10.12998/wjcc.v7.i16.2269
|
| 112 |
Magdalena Stepien, Pekka Keski‐Rahkonen, Agneta Kiss, Nivonirina Robinot, Talita Duarte‐Salles, Neil Murphy, Gabriel Perlemuter, Vivian Viallon, Anne Tjønneland, Agnetha Linn Rostgaard‐Hansen, Christina C. Dahm, Kim Overvad, Marie‐Christine Boutron‐Ruault, Francesca Romana Mancini, Yahya Mahamat‐Saleh, Krasimira Aleksandrova, Rudolf Kaaks, Tilman Kühn, Antonia Trichopoulou, Anna Karakatsani, Salvatore Panico, Rosario Tumino, Domenico Palli, Giovanna Tagliabue, Alessio Naccarati, Roel C.H. Vermeulen, Hendrik Bastiaan Bueno‐de‐Mesquita, Elisabete Weiderpass, Guri Skeie, Jose Ramón Quirós, Eva Ardanaz, Olatz Mokoroa, Núria Sala, Maria‐Jose Sánchez, José María Huerta, Anna Winkvist, Sophia Harlid, Bodil Ohlsson, Klas Sjöberg, Julie A. Schmidt, Nick Wareham, Kay‐Tee Khaw, Pietro Ferrari, Joseph A. Rothwell, Marc Gunter, Elio Riboli, Augustin Scalbert, Mazda Jenab. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study. International Journal of Cancer 2021; 148(3): 609 doi: 10.1002/ijc.33236
|
| 113 |
Yueyue Yang, Jiafei Lin, Susu Guo, Xiangfei Xue, Yikun Wang, Shiyu Qiu, Jiangtao Cui, Lifang Ma, Xiao Zhang, Jiayi Wang. RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01689-8
|
| 114 |
Lateef A. Sulaimon, Rahmat A. Adisa, Titilola A. Samuel, Fatimah B. Abdulkareem, Akinrinade G. Ayankojo. Mitoquinol mesylate alleviates oxidative damage in cirrhotic and advanced hepatocellular carcinogenic rats through mitochondrial protection and antioxidative effects. Advances in Redox Research 2021; 3: 100014 doi: 10.1016/j.arres.2021.100014
|
| 115 |
Rupie Jamwal, Venkatram Krishnan, Dinesh Singh Kushwaha, Rajat Khurana. Hepatocellular carcinoma in non-cirrhotic versus cirrhotic liver: a clinico-radiological comparative analysis. Abdominal Radiology 2020; 45(8): 2378 doi: 10.1007/s00261-020-02561-z
|
| 116 |
Haeryoung Kim, Wei-Qiang Leow, Regina Lo, Paulo Giovanni L. Mendoza, Anthony Wing-Hung Chan. Atlas of Hepatocellular Carcinoma Pathology. 2022; : 1 doi: 10.1007/978-981-16-8500-2_1
|
| 117 |
Xiaobin Chi, Zhijian Chen, Yongbiao Chen, Hanyin Hong, Jianda Yu, Lizhi Lv. Upregulation of lncRNA PTOV1‐AS1 in hepatocellular carcinoma contributes to disease progression and sorafenib resistance through regulating miR‐505. Journal of Biochemical and Molecular Toxicology 2023; 37(10) doi: 10.1002/jbt.23437
|
| 118 |
Han Deng, Wenting Shang, Kun Wang, Kunxiong Guo, Yu Liu, Jie Tian, Chihua Fang. Targeted-detection and sequential-treatment of small hepatocellular carcinoma in the complex liver environment by GPC-3-targeted nanoparticles. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01378-w
|
| 119 |
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Razie Hadavi, Ameneh Koochaki, Mahdi Paryan. Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma. Molecular Biology Reports 2020; 47(10): 7429 doi: 10.1007/s11033-020-05798-5
|
| 120 |
Benjamin Buchard, Camille Teilhet, Natali Abeywickrama Samarakoon, Sylvie Massoulier, Juliette Joubert-Zakeyh, Corinne Blouin, Christelle Reynes, Robert Sabatier, Anne-Sophie Biesse-Martin, Marie-Paule Vasson, Armando Abergel, Aicha Demidem. Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis Severity. Metabolites 2021; 11(1): 54 doi: 10.3390/metabo11010054
|
| 121 |
Luis Cesar Bredt, Ingryd Betina Garcia Felisberto, Doroty Eva Garcia Felisberto. Is there a role for liver transplantation in the treatment of hepatocellular carcinoma in non-cirrhotic liver?. World Journal of Meta-Analysis 2022; 10(2): 46-51 doi: 10.13105/wjma.v10.i2.46
|
| 122 |
Zongren Ding, Kongying Lin, Jun Fu, Qizhen Huang, Guoxu Fang, Yanyan Tang, Wuyi You, Zhaowang Lin, Zhan Lin, Xingxi Pan, Yongyi Zeng. An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02266-7
|
| 123 |
Afsaneh Barzi, Kali Zhou, Songren Wang, Jennifer L. Dodge, Anthony El-Khoueiry, Veronica Wendy Setiawan. Etiology and Outcomes of Hepatocellular Carcinoma in an Ethnically Diverse Population: The Multiethnic Cohort. Cancers 2021; 13(14): 3476 doi: 10.3390/cancers13143476
|
| 124 |
Jennie Engstrand, Per Stål, Stefan Gilg, Anders Jansson, Cecilia Strömberg. Hepatocellular carcinoma in cirrhotic versus non-cirrhotic liver: Treatment and survival differences in a nationwide cohort. Scandinavian Journal of Surgery 2023; doi: 10.1177/14574969231220179
|
| 125 |
Said A. Al-Busafi, Khalid AlNaamani. Liver Cancer in the Middle East. 2021; : 259 doi: 10.1007/978-3-030-78737-0_17
|
| 126 |
Catherine Leyh, Jason D. Coombes, Hartmut H. Schmidt, Ali Canbay, Paul P. Manka, Jan Best. MASLD-Related HCC—Update on Pathogenesis and Current Treatment Options. Journal of Personalized Medicine 2024; 14(4): 370 doi: 10.3390/jpm14040370
|
| 127 |
Manfred Schmidt, Graham R. Foster, Michiel Coppens, Hauke Thomsen, Ricardo Dolmetsch, Liesbeth Heijink, Paul E. Monahan, Steven W. Pipe. Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B. Blood Advances 2023; 7(17): 4966 doi: 10.1182/bloodadvances.2023009876
|
| 128 |
Manisri Porukala, P. K. Vinod, Amy McCart Reed. Gene expression signatures of stepwise progression of Hepatocellular Carcinoma. PLOS ONE 2023; 18(12): e0296454 doi: 10.1371/journal.pone.0296454
|
| 129 |
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]. 2019; doi: 10.5772/intechopen.86638
|
| 130 |
Stefano Mazza, Chiara Frigerio, Daniele Alfieri, Aurelio Mauro, Francesca Torello Viera, Davide Scalvini, Chiara Barteselli, Carmelo Sgarlata, Letizia Veronese, Marco Bardone, Laura Rovedatti, Simona Agazzi, Elena Strada, Lodovica Pozzi, Marcello Maestri, Valentina Ravetta, Andrea Anderloni. Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative Treatment. Medicina 2024; 60(5): 692 doi: 10.3390/medicina60050692
|
| 131 |
Na Young Lee, Ki Tae Suk. The Role of the Gut Microbiome in Liver Cirrhosis Treatment. International Journal of Molecular Sciences 2020; 22(1): 199 doi: 10.3390/ijms22010199
|
| 132 |
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Ragesh B Thandassery, Emmanouil Giorgakis. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements. World Journal of Gastroenterology 2021; 27(24): 3466-3482 doi: 10.3748/wjg.v27.i24.3466
|
| 133 |
Shintaro Ichikawa, Hiroyuki Morisaka, Yoshie Omiya, Hiroshi Onishi. Distinction Between Hepatocellular Carcinoma and Hypervascular Liver Metastases in Non-cirrhotic Patients Using Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging. Canadian Association of Radiologists Journal 2022; 73(4): 639 doi: 10.1177/08465371221085516
|
| 134 |
Sonia Triggiani, Maria T. Contaldo, Giulia Mastellone, Maurizio Cè, Anna M. Ierardi, Gianpaolo Carrafiello, Michaela Cellina.
The Role of Artificial Intelligence and Texture Analysis in Interventional Radiological Treatments of Liver Masses: A Narrative Review
. Critical Reviews™ in Oncogenesis 2024; 29(2): 37 doi: 10.1615/CritRevOncog.2023049855
|
| 135 |
Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik. Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events. Digestive Diseases and Sciences 2021; 66(8): 2816 doi: 10.1007/s10620-020-06591-x
|
| 136 |
Naima Zayed Mohamed, Hanan Farouk Aly, Hatem Abdel moneim El-Mezayen, Hadeer E. El-Salamony. Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in rats. Toxicology Reports 2019; 6: 875 doi: 10.1016/j.toxrep.2019.08.007
|
| 137 |
Susanne Feder, Arne Kandulski, Doris Schacherer, Thomas S. Weiss, Christa Buechler. Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma. International Journal of Molecular Sciences 2019; 20(16): 3919 doi: 10.3390/ijms20163919
|
| 138 |
Robert M. Shavelle, Ji Hun Kwak, Rachel Saur, Jordan C. Brooks, Philip Rosenthal. Life Expectancy after Liver Transplantation for Non-Cirrhotic Hepatocellular Carcinoma. Progress in Transplantation 2021; 31(2): 117 doi: 10.1177/15269248211002793
|
| 139 |
Siyu Fu, Teoman Deger, Ruben G. Boers, Joachim B. Boers, Michael Doukas, Joost Gribnau, Saskia M. Wilting, José D. Debes, Andre Boonstra. Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma. Cancers 2023; 15(19): 4784 doi: 10.3390/cancers15194784
|
| 140 |
Gianni TESTINO, Sharmila FAGOONEE, Fabio CAPUTO, Rinaldo PELLICANO. The early identification of alcohol use disorders and liver injury: proposal for a diagnostic algorithm. Panminerva Medica 2021; 63(3) doi: 10.23736/S0031-0808.21.04272-5
|
| 141 |
Giovanni Vitale, Alessandro Mattiaccio, Amalia Conti, Laura Turco, Marco Seri, Fabio Piscaglia, Maria Cristina Morelli. Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the Literature. Cancers 2022; 14(14): 3421 doi: 10.3390/cancers14143421
|
| 142 |
Cristiane Valle Tovo, Angelo Zambam de Mattos, Gabriela Perdomo Coral, Giovana D P Sartori, Livia Villela Nogueira, Gustavo Tovo Both, Cristiane A Villela-Nogueira, Angelo A de Mattos. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis. World Journal of Gastroenterology 2023; 29(2): 343-356 doi: 10.3748/wjg.v29.i2.343
|
| 143 |
Juliet Emamaullee, Ali N. Zaidi, Thomas Schiano, Jeffrey Kahn, Pamela L. Valentino, Ryan E. Hofer, Timucin Taner, Joyce W. Wald, Kim M. Olthoff, John Bucuvalas, Ryan Fischer. Fontan-Associated Liver Disease. Circulation 2020; 142(6): 591 doi: 10.1161/CIRCULATIONAHA.120.045597
|
| 144 |
Ayoob Dinar Abdullah, Behzad Amanpour-Gharaei, Mohssen Nassiri Toosi, Sina Delazar, Hamidraza Saligheh Rad, Arvin Arian. Comparing Texture Analysis of Apparent Diffusion Coefficient MRI in Hepatocellular Adenoma and Hepatocellular Carcinoma. Cureus 2024; doi: 10.7759/cureus.51443
|
| 145 |
Ahmed M Badheeb, Mohammed K Al Sedran, Faisal Ahmed, Ibrahim K Al Sidran, Mohammed H Al Qurayshah, Abdullah Abu Bakar, Hamoud Y Obied, Islam A Seada, Abdelaziz Aman, Mohamed Badheeb. Clinical Characteristics and Survival of Hepatocellular Carcinoma: Insights from Single-Centre Experience in Saudi Arabia. Cureus 2024; doi: 10.7759/cureus.52608
|
| 146 |
Qimeng Chang, Yayun Xu, Jianfa Wang, Hui Jing, Longhua Rao, Weiguo Tang, Ziping Zhang, Xubo Wu, Jianxin Shi. SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/8556888
|
| 147 |
Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Silvia Gaia, Emanuela Rolle, Alessandra Risso, Daniela Campion, Paola Rita Brunocilla, Giorgio Maria Saracco, Patrizia Carucci. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy. Current Oncology 2022; 29(3): 1422 doi: 10.3390/curroncol29030119
|
| 148 |
Dina Sweed, Enas Sweed, Inas Moaz, Asmaa Mosbeh, Yahya Fayed, Sara Mohamed Abd Elhamed, Eman Sweed, Mahmoud Macshut, Shimaa Abdelsattar, Shimaa Kilany, Sara A. Saied, Reda Badr, Mahmoud S. Abdallah, Nermine Ehsan. The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02764-2
|
| 149 |
A. Riojas-Garza, M. González-Urquijo, C.E. Escareño-Pérez, I. Vázquez-Ávila, F.J. Bosques-Padilla. Caudate lobe hepatocellular carcinoma in a noncirrhotic patient with a history of chronic phenytoin intake and celiac disease treated with isolated caudate lobe resection. A case report. Revista de Gastroenterología de México (English Edition) 2022; 87(2): 256 doi: 10.1016/j.rgmxen.2022.05.011
|
| 150 |
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation. 2021; : 89 doi: 10.1016/B978-0-7020-7584-1.00006-1
|
| 151 |
Abid M. Sadiq, Tendai J. Mashonganyika, Lilian G. Mmbaga, Adnan M. Sadiq, Gilbert Z. Nkya. Hepatocellular carcinoma in a non‐cirrhotic liver with a tumor thrombus. Clinical Case Reports 2021; 9(9) doi: 10.1002/ccr3.4800
|
| 152 |
Wasitha P.D. Wass Thilakarathna, H.P. Vasantha Rupasinghe, Neale D. Ridgway. Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(5): 2606 doi: 10.3390/ijms22052606
|
| 153 |
Sarah El-Nakeep. Molecular and genetic markers in hepatocellular carcinoma: <i>In silico </i>analysis to clinical validation (current limitations and future promises). World Journal of Gastrointestinal Pathophysiology 2022; 13(1): 1-14 doi: 10.4291/wjgp.v13.i1.1
|
| 154 |
Sancharan Acharya, Subramaniyam Nithyananthan, Chinnasamy Thirunavukkarasu. Selenium Nanoparticles Show Anticancer Activity Through Regulation of HIF-1α and HIF-2α Under Hypoxic Condition in Liver Cancer Cells. DNA and Cell Biology 2023; 42(7): 433 doi: 10.1089/dna.2023.0099
|
| 155 |
Akiko Eguchi, Motoh Iwasa, Minori Yamada, Yasuyuki Tamai, Ryuta Shigefuku, Hiroshi Hasegawa, Yoshifumi Hirokawa, Akinobu Hayashi, Koji Okuno, Yuki Matsushita, Takuma Nakatsuka, Kenichiro Enooku, Koji Sakaguchi, Yoshinao Kobayashi, Tetsuji Yamaguchi, Masatoshi Watanabe, Yoshiyuki Takei, Hayato Nakagawa. A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis. Hepatology Communications 2022; 6(8): 1987 doi: 10.1002/hep4.1971
|
| 156 |
Clara Bihain, Jean Delwaide, Paul Meunier, Laurent Gerard, Alexandre Jadoul, Olivier Detry. Successful multimodal management of a large hepatocellular carcinoma in a non-cirrhotic liver: a case report. Acta Chirurgica Belgica 2023; : 1 doi: 10.1080/00015458.2023.2234724
|
| 157 |
Joscha Vonderlin, Triantafyllos Chavakis, Michael Sieweke, Frank Tacke. The Multifaceted Roles of Macrophages in NAFLD Pathogenesis. Cellular and Molecular Gastroenterology and Hepatology 2023; 15(6): 1311 doi: 10.1016/j.jcmgh.2023.03.002
|
| 158 |
Srikanta Dash, Yucel Aydin, Kyle E Widmer, Leela Nayak. <p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>. Journal of Hepatocellular Carcinoma 2020; : 45 doi: 10.2147/JHC.S221187
|
| 159 |
Adrià Ramírez Mena, Mbaye Thiam, Daye Ka, Ibrahima Niang, Judicaël Tine, Louise Fortes, Kiné Ndiaye, Ousseynou Ndiaye, Maguette Fall, Assietou Gaye, Ndeye Fatou Ngom, Fatou Fall, Annalisa Berzigotti, Gregory Dale Kirk, Antoine Jaquet, Moussa Seydi, Gilles Wandeler. Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study. The Lancet Gastroenterology & Hepatology 2024; doi: 10.1016/S2468-1253(24)00040-2
|
| 160 |
Kazuma Sekiba, Motoyuki Otsuka, Kazuhiko Koike. Potential of HBx Gene for Hepatocarcinogenesis in Noncirrhotic Liver. Seminars in Liver Disease 2021; 41(02): 142 doi: 10.1055/s-0041-1723033
|
| 161 |
Zhenghong Lee, Zheng-Rong Lu, Sandra Sexton, Wei Xin. PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 2023; 50(11): 3190 doi: 10.1007/s00259-023-06324-y
|
| 162 |
Santhosh Anand, Loganathan Jayapal, Siddhesh Suresh Tasgaonkar Ema, Jainudeen Khalander Abdul Jameel, Prasanna Kumar Reddy. Laparoscopic right posterior sectionectomy for a large hepatocellular carcinoma close to inferior vena cava. Journal of Minimally Invasive Surgery 2023; 26(3): 162 doi: 10.7602/jmis.2023.26.3.162
|
| 163 |
Yu-Jen Chen, Chien-Wei Su, Cheng-Yi Wei, Gar-Yang Chau, Ping-Hsien Chen, Yee Chao, Yi-Hsiang Huang, Jaw-Ching Wu, Tsung-Chieh Yang, Pei-Chang Lee, Ming-Chih Hou. Comparison of prognoses between cirrhotic and noncirrhotic patients with hepatocellular carcinoma and esophageal varices undergoing surgical resection. Journal of the Chinese Medical Association 2022; 85(6): 679 doi: 10.1097/JCMA.0000000000000739
|
| 164 |
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocrine Reviews 2020; 41(1): 66 doi: 10.1210/endrev/bnz009
|
| 165 |
Hsin-Yeh Chen, Kwong-Ming Kee, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Yuan-Hung Kuo. Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolization. Journal of the Formosan Medical Association 2022; 121(4): 778 doi: 10.1016/j.jfma.2021.07.003
|
| 166 |
Priya Singh, Parul Gupta, Arka De, Ajay Duseja. Molecular Characterization of Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis: Implications for Immunotherapy. Journal of Clinical and Experimental Hepatology 2023; 13(6): 1140 doi: 10.1016/j.jceh.2023.03.001
|
| 167 |
Ruzan Udumyan, Scott Montgomery, Ann-Sofi Duberg, Fang Fang, Unnur Valdimarsdottir, Anders Ekbom, Karin E. Smedby, Katja Fall. Beta-adrenergic receptor blockers and liver cancer mortality in a national cohort of hepatocellular carcinoma patients. Scandinavian Journal of Gastroenterology 2020; 55(5): 597 doi: 10.1080/00365521.2020.1762919
|
| 168 |
Xuan-vinh Kevin Nguyen, Jason Zhang, Ken Lee Chin, Stephen Bloom, Amanda J. Nicoll. Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?. Nutrients 2022; 14(18): 3875 doi: 10.3390/nu14183875
|
| 169 |
Georgi Atanasov, Karoline Dino, Katrin Schierle, Corinna Dietel, Gabriela Aust, Johann Pratschke, Daniel Seehofer, Moritz Schmelzle, Hans-Michael Hau. Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1635-3
|
| 170 |
Norberto C Chavez-Tapia, Sofía Murúa-Beltrán Gall, Ana Luisa Ordoñez-Vázquez, Natalia Nuño-Lambarri, Paulina Vidal-Cevallos, Misael Uribe. Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 583 doi: 10.2147/JHC.S283840
|
| 171 |
Scott L. Friedman, Arun J. Sanyal. The future of hepatology. Hepatology 2023; 78(2): 637 doi: 10.1097/HEP.0000000000000389
|
| 172 |
Sheng Chen, Yi-Jie Qiu, Dan Zuo, Shuai-Nan Shi, Wen-Ping Wang, Yi Dong. Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced Ultrasound. Diagnostics 2022; 12(10): 2272 doi: 10.3390/diagnostics12102272
|
| 173 |
Jong Man Kim, Jinsoo Rhu, Sang Yun Ha, Gyu-Seong Choi, Choon Hyuck David Kwon, Jae-Won Joh. Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis. Annals of Surgical Treatment and Research 2022; 102(1): 1 doi: 10.4174/astr.2022.102.1.1
|
| 174 |
Sangmi Jang, Young-Joo Jin, Jin-Woo Lee, Dam Kwon, Jung Hwan Yu. Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillance. Medicine 2023; 102(32): e34637 doi: 10.1097/MD.0000000000034637
|
| 175 |
Arun Kumar Gunasekaran, Amit Malviya, Tony Ete, Animesh Mishra, Bhupen Barman, Md Jamil, Donboklang Lynser. Hepatocellular Carcinoma with Inferior Vena Cava and Right Atrium Tumor Thrombus. Acta medica Lituanica 2021; 28(2): 10 doi: 10.15388/Amed.2021.28.2.10
|
| 176 |
Martijn P.A. Starmans, Razvan L. Miclea, Valerie Vilgrain, Maxime Ronot, Yvonne Purcell, Jef Verbeek, Wiro J. Niessen, Jan N.M. Ijzermans, Rob A. de Man, Michael Doukas, Stefan Klein, Maarten G. Thomeer. Automated Assessment of T2-Weighted MRI to Differentiate Malignant and Benign Primary Solid Liver Lesions in Noncirrhotic Livers Using Radiomics. Academic Radiology 2024; 31(3): 870 doi: 10.1016/j.acra.2023.07.024
|
| 177 |
Brian McMahon, Chari Cohen, Robert S Brown Jr, Hashem El-Serag, George N Ioannou, Anna S Lok, Lewis R Roberts, Amit G Singal, Timothy Block. Opportunities to address gaps in early detection and improve outcomes of liver cancer. JNCI Cancer Spectrum 2023; 7(3) doi: 10.1093/jncics/pkad034
|
| 178 |
Lampros Chrysavgis, Ilias Giannakodimos, Panagiota Diamantopoulou, Evangelos Cholongitas. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. World Journal of Gastroenterology 2022; 28(3): 310-331 doi: 10.3748/wjg.v28.i3.310
|
| 179 |
Eloy Ruiz, Jorge Honles, Ramiro Fernández, Karla Uribe, Juan P. Cerapio, Karina Cancino, Juan Contreras-Mancilla, Sandro Casavilca-Zambrano, Francisco Berrospi, Pascal Pineau, Stéphane Bertani. A preoperative risk score based on early recurrence for estimating outcomes after resection of hepatocellular carcinoma in the non-cirrhotic liver. HPB 2024; doi: 10.1016/j.hpb.2024.02.010
|
| 180 |
Jing Yao, Zhe Yang, Jun Yang, Zhi-Gang Wang, Zheng-Yun Zhang. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis. Aging 2021; 13(10): 13726 doi: 10.18632/aging.202960
|
| 181 |
Anisha Jain, Benjamin Mazer, Yanhong Deng, Maria Ciarleglio, Dhanpat Jain, Tamar Taddei, Xuchen Zhang. Hepatocellular Carcinoma. American Journal of Clinical Pathology 2022; 157(2): 305 doi: 10.1093/ajcp/aqab125
|
| 182 |
Haeryoung Kim, Wei-Qiang Leow, Regina Lo, Paulo Giovanni L. Mendoza, Anthony Wing-Hung Chan. Atlas of Hepatocellular Carcinoma Pathology. 2022; : 3 doi: 10.1007/978-981-16-8500-2_2
|
| 183 |
Daniel Q. Huang, Hashem B. El-Serag, Rohit Loomba. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology 2021; 18(4): 223 doi: 10.1038/s41575-020-00381-6
|
| 184 |
L.E. Cisneros-Garza, M.S. González-Huezo, C. Moctezuma-Velázquez, L. Ladrón de Guevara-Cetina, M. Vilatobá, I. García-Juárez, R. Alvarado-Reyes, G.A. Álvarez-Treviño, S. Allende-Pérez, L. Bornstein-Quevedo, G. Calderillo-Ruiz, M.A. Carrillo-Martínez, M. Castillo-Barradas, E. Cerda-Reyes, J.A. Félix-Leyva, J.A. Gabutti-Thomas, J. Guerrero-Ixtlahuac, F. Higuera-de-la-Tijera, D. Huitzil-Meléndez, E. Kimura-Hayama, P.A. López-Hernández, R. Malé-Velázquez, N. Méndez-Sánchez, M.A. Morales-Ruiz, E. Ruíz-García, J.F. Sánchez-Ávila, L. Torrecillas-Torres. II Consenso Mexicano de Carcinoma Hepatocelular. Parte I: Epidemiología y diagnóstico. Revista de Gastroenterología de México 2022; 87(2): 216 doi: 10.1016/j.rgmx.2021.10.002
|
| 185 |
Stefania Brozzetti, Chiara D’Alterio, Simone Bini, Jessica Antimi, Bianca Rocco, Alessia Fassari, Pierleone Lucatelli, Piergiorgio Nardis, Michele Di Martino, Giuseppe Maria De Sanctis, Mario Corona, Oreste Bagni, Enrico Cortesi, Mario Bezzi, Carlo Catalano. Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients—A Retrospective Observational Study. Cancers 2022; 14(18): 4422 doi: 10.3390/cancers14184422
|
| 186 |
Alisa A. Petkevich, Aleksandr A. Abramov, Vadim I. Pospelov, Natalya A. Malinina, Elena I. Kuhareva, Natalya V. Mazurchik, Olga I. Tarasova. Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer. Oncotarget 2021; 12(17): 1697 doi: 10.18632/oncotarget.28036
|
| 187 |
Saleh A. Alqahtani, Wah-Kheong Chan, Ming-Lung Yu. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma. Clinics in Liver Disease 2023; 27(2): 211 doi: 10.1016/j.cld.2023.01.019
|
| 188 |
Sofi Dhanaraj, Tahir Shah, Joanne O'Rourke, Shishir Shetty. Hepatocellular carcinoma: update on treatment guidelines. Gastrointestinal Nursing 2020; 18(Sup10): S18 doi: 10.12968/gasn.2020.18.Sup10.S18
|